Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript March 20, 2025
Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.23, expectations were $-0.37.
Operator: Greetings, and welcome to Monte Rosa Therapeutics Conference Call to discuss the company’s pipeline updates and clinical results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference...
